WHO ICTRP trial
A prospective study to evaluate the immune response of UK infants receiving the…
EUCTR2010-023865-22-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-023865-22-GB |
|---|---|
| Public title | A prospective study to evaluate the immune response of UK infants receiving the 13-valent pneumococcal conjugate vaccine as part of their routine primary immunisation schedule at 2 and 4 months (code: P13UK) - P13UK |
| Scientific title | A prospective study to evaluate the immune response of UK infants receiving the 13-valent pneumococcal conjugate vaccine as part of their routine primary immunisation schedule at 2 and 4 months (code: P13UK) - P13UK |
| Primary sponsor | Health Protection Agency |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Prevenar13 was introduced into the national childhood immunisation programme to prevent serious bacterial infections caused by the germ Streptococcus pneumonia, including meningitis, septicaemia and pneumonia. |
| Interventions | Trade Name: Prevenar13 Product Name: Prevenar 13 Pharmaceutical Form: Injection* INN or Proposed INN: Pneumococcal polysaccharide type 1 Concentration unit: µg microgram(s) Concentration type: equal Concentration number: 2.2- INN or… |
| Registration date | Jul 12, 2010 |
| Target size | 200 |
| Secondary IDs | P13UK |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: